P.M. Fracasso
Department of Medicine
Washington University School of Medicine
St Louis
USA
Name/email consistency: high
- Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. Fracasso, P.M., Westervelt, P., Fears, C.L., Rosen, D.M., Zuhowski, E.G., Cazenave, L.A., Litchman, M., Egorin, M.J., Westerveldt, P., Fears, C.A. J. Clin. Oncol. (2000)









